A phase II trial of phenoxodiol [idronoxil] in patients with castrate and non-castrate prostate cancer
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2015
At a glance
- Drugs Idronoxil (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors MEI Pharma
- 10 Jun 2017 Biomarkers information updated
- 21 May 2010 Results will be reported at ASCO, according to a Marshall Edwards medai release.
- 09 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.